133 related articles for article (PubMed ID: 38128350)
1. Beneficial carry-over effects of chronic at-home genital nerve stimulation on incontinence in individuals with spinal cord injury: A pragmatic trial.
Yeh SD; Khasanah N; Gustafson KJ; Sun C; Tsai ML; Lin BS; Wu CW; Peng CW
Ann Phys Rehabil Med; 2024 Mar; 67(2):101799. PubMed ID: 38128350
[TBL] [Abstract][Full Text] [Related]
2. At-home genital nerve stimulation for individuals with SCI and neurogenic detrusor overactivity: A pilot feasibility study.
Bourbeau DJ; Gustafson KJ; Brose SW
J Spinal Cord Med; 2019 May; 42(3):360-370. PubMed ID: 29334338
[TBL] [Abstract][Full Text] [Related]
3. Effects of repetitive functional magnetic stimulation in the sacral nerve in patients with neurogenic detrusor overactivity after suprasacral spinal cord injury: a study protocol for a randomized controlled trial.
Li J; Wang J; Hu Y; Jian R; Zhao Y; Li D; Wan T; Jike W; Xu F; Huang M
Trials; 2023 Mar; 24(1):199. PubMed ID: 36932375
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial.
Cruz F; Herschorn S; Aliotta P; Brin M; Thompson C; Lam W; Daniell G; Heesakkers J; Haag-Molkenteller C
Eur Urol; 2011 Oct; 60(4):742-50. PubMed ID: 21798658
[TBL] [Abstract][Full Text] [Related]
5. Genital nerve stimulation is tolerable and effective for bladder inhibition in sensate individuals with incomplete SCI.
Brose SW; Bourbeau DJ; Gustafson KJ
J Spinal Cord Med; 2018 Mar; 41(2):174-181. PubMed ID: 28185483
[TBL] [Abstract][Full Text] [Related]
6. Protocol for a randomized clinical trial investigating early sacral nerve stimulation as an adjunct to standard neurogenic bladder management following acute spinal cord injury.
Redshaw JD; Lenherr SM; Elliott SP; Stoffel JT; Rosenbluth JP; Presson AP; Myers JB;
BMC Urol; 2018 Aug; 18(1):72. PubMed ID: 30157824
[TBL] [Abstract][Full Text] [Related]
7. Genital nerve stimulation increases bladder capacity after SCI: A meta-analysis.
Bourbeau DJ; Creasey GH; Sidik S; Brose SW; Gustafson KJ
J Spinal Cord Med; 2018 Jul; 41(4):426-434. PubMed ID: 28198657
[TBL] [Abstract][Full Text] [Related]
8. OnabotulinumtoxinA improves urodynamic outcomes in patients with neurogenic detrusor overactivity.
Rovner E; Dmochowski R; Chapple C; Thompson C; Lam W; Haag-Molkenteller C
Neurourol Urodyn; 2013 Nov; 32(8):1109-15. PubMed ID: 23389824
[TBL] [Abstract][Full Text] [Related]
9. Subject-controlled stimulation of dorsal genital nerve to treat neurogenic detrusor overactivity at home.
Opisso E; Borau A; Rijkhoff NJ
Neurourol Urodyn; 2013 Sep; 32(7):1004-9. PubMed ID: 23281007
[TBL] [Abstract][Full Text] [Related]
10. Solifenacin is effective and well tolerated in patients with neurogenic detrusor overactivity: Results from the double-blind, randomized, active- and placebo-controlled SONIC urodynamic study.
Amarenco G; Sutory M; Zachoval R; Agarwal M; Del Popolo G; Tretter R; Compion G; De Ridder D
Neurourol Urodyn; 2017 Feb; 36(2):414-421. PubMed ID: 26714009
[TBL] [Abstract][Full Text] [Related]
11. Effects of Bilateral Transcutaneous Tibial Nerve Stimulation on Neurogenic Detrusor Overactivity in Spinal Cord Injury: A Urodynamic Study.
Kamboonlert K; Panyasriwanit S; Tantisiriwat N; Kitisomprayoonkul W
Arch Phys Med Rehabil; 2021 Jun; 102(6):1165-1169. PubMed ID: 33245938
[TBL] [Abstract][Full Text] [Related]
12. Injections of Botulinum Toxin A into the detrusor to treat neurogenic detrusor overactivity secondary to spinal cord injury.
Chen G; Liao L
Int Urol Nephrol; 2011 Sep; 43(3):655-62. PubMed ID: 21110094
[TBL] [Abstract][Full Text] [Related]
13. An exploratory, placebo-controlled, dose-response study of the efficacy and safety of onabotulinumtoxinA in spinal cord injury patients with urinary incontinence due to neurogenic detrusor overactivity.
Apostolidis A; Thompson C; Yan X; Mourad S
World J Urol; 2013 Dec; 31(6):1469-74. PubMed ID: 23160758
[TBL] [Abstract][Full Text] [Related]
14. A pilot randomized-controlled trial of the urodynamic efficacy of mirabegron for patients with neurogenic lower urinary tract dysfunction.
Welk B; Hickling D; McKibbon M; Radomski S; Ethans K
Neurourol Urodyn; 2018 Nov; 37(8):2810-2817. PubMed ID: 30168626
[TBL] [Abstract][Full Text] [Related]
15. Supratrigonal cystectomy with Hautmann pouch as treatment for neurogenic bladder in spinal cord injury patients: long-term functional results.
Gobeaux N; Yates DR; Denys P; Even-Schneider A; Richard F; Chartier-Kastler E
Neurourol Urodyn; 2012 Jun; 31(5):672-6. PubMed ID: 22532256
[TBL] [Abstract][Full Text] [Related]
16. AbobotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor overactivity regardless of spinal cord injury or multiple sclerosis etiology: Pooled analysis of two phase III randomized studies (CONTENT1 and CONTENT2).
Denys P; Castaño Botero JC; Vita Nunes RL; Wachs B; Mendes Gomes C; Krivoborodov G; Tu LM; Del-Popolo G; Thompson C; Vilain C; Volteau M; Kennelly M;
Neurourol Urodyn; 2023 Jan; 42(1):153-167. PubMed ID: 36321799
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of trigonal BTX-A injections for children with neurological detrusor overactivity secondary to spinal cord injury.
Hui C
J Pediatr Surg; 2020 Dec; 55(12):2736-2739. PubMed ID: 32571538
[TBL] [Abstract][Full Text] [Related]
18. TASCI-transcutaneous tibial nerve stimulation in patients with acute spinal cord injury to prevent neurogenic detrusor overactivity: protocol for a nationwide, randomised, sham-controlled, double-blind clinical trial.
Birkhäuser V; Liechti MD; Anderson CE; Bachmann LM; Baumann S; Baumberger M; Birder LA; Botter SM; Büeler S; Cruz CD; David G; Freund P; Friedl S; Gross O; Hund-Georgiadis M; Husmann K; Jordan X; Koschorke M; Leitner L; Luca E; Mehnert U; Möhr S; Mohammadzada F; Monastyrskaya K; Pfender N; Pohl D; Sadri H; Sartori AM; Schubert M; Sprengel K; Stalder SA; Stoyanov J; Stress C; Tatu A; Tawadros C; van der Lely S; Wöllner J; Zubler V; Curt A; Pannek J; Brinkhof MWG; Kessler TM
BMJ Open; 2020 Aug; 10(8):e039164. PubMed ID: 32792454
[TBL] [Abstract][Full Text] [Related]
19. OnabotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor overactivity [corrected] regardless of concomitant anticholinergic use or neurologic etiology.
Ginsberg D; Cruz F; Herschorn S; Gousse A; Keppenne V; Aliotta P; Sievert KD; Brin MF; Jenkins B; Thompson C; Lam W; Heesakkers J; Haag-Molkenteller C
Adv Ther; 2013 Sep; 30(9):819-33. PubMed ID: 24072665
[TBL] [Abstract][Full Text] [Related]
20. Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results.
Giannantoni A; Mearini E; Del Zingaro M; Porena M
Eur Urol; 2009 Mar; 55(3):705-11. PubMed ID: 18814955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
